Day 1 Day 2Time Diciplinary Speaker

0730-0800 Registration 0800-0810 Opening Ceremony

SESSION I : PROSTATE AND BREAST

0810-0835 The Relationship of Rin Yamaguchi, Molecular Subtypes and Singapore Histological Types0835-0900 Update in Molecular Gary Tse, Hongkong Classification0900-0925 Myoepithelial Markers in Puay Hoon Tan, Breast Pathology Singapore0925-0950 Benign mimics of Prostate Puay Hoon Tan, Cancer: How Not to Fall Singapore into Traps 0950-1005 BREAK

SESSION II : HEMATOLYMPHOID

1005-1030 Immuniphenotypic Analysis Daisuke Niino, Japan in the Diagnosis and ClassificationofMalignant Lymphoma 1030-1055 Differential Diagnoses and Shahid Pervez, Diagnostic Approach for Pakistan Lymphomas with Nodular (Follicular) Pattern 1055-1120 Pongsak Waranakriot, Thailand1120-1135 BREAK

SESSION III : KEYNOTE LECTURE

1135-1215 New ASCO/CAP Guidelines Michael Bilous, for HER2 Testing in Australia Breast Cancer 1215-1255 The Emerging Role of Bharat Jasani, Molecular Pathology in United Kingdom Improving Cancer Outcomes in Advanced Colorectal Cancer

SESSION I : ENDOCRINE

0800-0825 Impact of Pathology in Robert Osamura, Japan the Clinical Practice of Pancreatic and GastroEnteric Neuroendocrine Tumors 0825-0850 Impact of Pathology in the Ryohei Kato, Japan Clinical Practice of Pancreatic and GastroEnteric Neuroendocrine Tumors 0850-0905 BREAK SESSION II : LUNG

0905-0920 Neuroendocrine Tumors in the Osamu Matsubara, Japan Lung, Old and New Aspects 0920-0940 Immunohistochemistry of Michelle Anne Ensinas-Latoy, Pulmonary Malignancies: Philippines The Lung Center of the Philippines Experience 0940-1000 Comparison of IHC, FISH, and Shiu-Feng Huang, RT-PCR Methods for Detection Taiwan of ALK Rearrangements in 312 Non-small Cell Lung Cancer Patients in Taiwan1005-1010 BREAK 1010-1030 Characteristics of Lung Yuichi Ishikawa, Adenocarcinoma of Asians in Japan Terms of ALK rearrangements and EGFR Mutations 1030-1050 Immunohistochemical and Kunyoung Kwon, scanning electron, microscopic Korea applicationusingParaffin embedded Pathologic Samples for Diagnosis of Malignant Mesothelioma 1150-1110 Jiping DA, China1115-1130 BREAK SESSION III : KEYNOTE LECTURE

1130-1210 Impact of HER2 Copy Bharat Jasani, Number in IHC HER2 2+/ United Kingdom FISH Positive Breast Cancer on Outcome of Adjuvant Trastuzumab Treatment 1210-1250 HER2 Testing in Gastric Michael Bilous, Australia Cancer

R e g i S T R a T i o n f o R m

Last Name

Hospital / Institution

First Name

Position

Home / Mailing Address

Contact Numbers

Landline Fax

Mobile #

Email

Zip Code

Middle Name

Address

For more information please visit our website:www.psp-apsmi.info